Exhibit 5.1
| | | | | | | | |
![LOGO](https://capedge.com/proxy/S-3/0001193125-21-293288/g197901g40j96.jpg) | | | | | | McCarter & English, LLP Four Gateway Center 100 Mulberry Street Newark, NJ 07102-4056 www.mccarter.com |
October 6, 2021
Delcath Systems, Inc.
1633 Broadway, Suite 22C
New York, NY 10019
Re: | Delcath Systems, Inc. Shelf Registration Statement on Form S-3 |
Ladies and Gentlemen:
We have acted as counsel to Delcath Systems, Inc., a Delaware corporation (the “Company”), in connection with the Company’s Registration Statement on Form S-3 (the “Registration Statement”) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (collectively, the “Act”). The Registration Statement relates to the offer and sale by the selling stockholders identified therein (the “Selling Stockholders”) of up to 638,199 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), consisting of (a) up to 237,614 shares of Common Stock that may be issued to Selling Stockholders upon the conversion of an aggregate of up to 2,376.14 shares of the Company’s Series E Convertible Preferred Stock, par value $0.01 per share (the “Series E Preferred Stock”), at a conversion price of $1,198 per share, following an election by such Selling Stockholders to convert the principal amount of, and all interest accruing under, 8% senior secured promissory notes issued by the Company to such Selling Stockholders (the principal of which is $2 million, and the accrued interest on which as of the date hereof is $344,556) into shares of Series E Preferred Stock, (b) up to an aggregate of 378,172 shares of Common Stock that may be issued to a Selling Stockholder, consisting of (i) 250,417 shares of Common Stock that may be issued to such Selling Stockholder upon the conversion of up to $3 million principal amount of a loan made to the Company by such Selling Stockholder (the “Loan”) and (ii) 127,755 shares of Common Stock that may be issued to such Selling Stockholder upon the exercise of a warrant for 127,755 shares of the Company’s Common Stock issued to such Selling Stockholder in connection with the Loan at an exercise price of $0.01 per share (the “Warrant”), and (c) 22,413 shares of Common Stock held by Selling Stockholders (collectively, the “Offering Shares”), which Offering Shares may be sold from time to time pursuant to Rule 415 under the Act. This opinion letter is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act.
In connection with this opinion letter, we have examined the following: (i) the Registration Statement, including the exhibits thereto, (ii) the Amended and Restated Certificate of Incorporation of the Company, as amended, as certified by the Secretary of the State of Delaware and as certified by the Secretary of the Company (the “Certificate of Incorporation”), (iii) the Amended and Restated Bylaws of the Company as currently in effect and as certified by the Secretary of the Company, (iv) a copy of certain resolutions of the Board of Directors of the Company, adopted on August 5, 2021, relating to the registration of the Securities, as certified by the Secretary of the Company and (v) such other documents, records and other instruments as we have deemed appropriate for purposes of the opinions set forth herein.
In such examination, we have assumed (i) the Registration Statement and any amendments thereto (including post-effective amendments) will have become effective; (ii) the Offering Shares will be offered and sold in compliance with applicable federal and state